Sarepta Therapeutics (SRPT) Tops Q2 EPS by 20c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. TGT
2. EL
3. SPY
4. WMT
5. ADI
6. ROST
7. BILL
8. MRK
9. MRNA
10. NTES

Go back to Sarepta Therapeutics (SRPT) Tops Q2 EPS by 20c

Sarepta Therapeutic (SRPT) PT Bumped to $35 at RBC Capital

August 7, 2015 8:21 AM EDT

RBC Capital analyst Simos Simeonidis reiterated a Sector Perform rating and boosted his price target on Sarepta Therapeutic (NASDAQ: SRPT) to $35.00 (from $20.00) to account for the potential value of eteplirsen's follow-on exon programs.

Simeonidis commented, "Sarepta updated investors on the progress of... More

Sarepta Therapeutic (SRPT) PT Raised to $47 at Baird; Increasingly Bullish on Risk/Reward

August 7, 2015 7:41 AM EDT

Baird analyst Brian Skorney reiterated an Outperform rating and boosted his price target on Sarepta Therapeutic (NASDAQ: SRPT) to $47.00 (from $34.00), saying they are increasingly bullish on risk/reward.

Sarepta commented, "After spending time with management recently and hearing additional granularity on the... More

SunTrust Downgrades Sarepta Therapeutic (SRPT) to Neutral

August 7, 2015 7:07 AM EDT

SunTrust Robinson Humphrey downgraded Sarepta Therapeutic (NASDAQ: SRPT) from Buy to Neutral with a price target of $33 (unchanged).

For an analyst ratings summary and ratings history on Sarepta Therapeutic click here. For more ratings news on Sarepta Therapeutic click here.

Shares of Sarepta Therapeutic closed at $34.63 yesterday.

... More